q&more
My watch list
my.chemie.de  
Login  

News

Tracking Down False Parkers in Cancer Cells

Markus Diefenbacher / Universität Würzburg

A lung tumor that expresses USP28 (left). On the right, however, tumors are shown in which USP28 has been "cut out" using the gene editing tool CRISPR/Cas9 – they are significantly smaller. The size bar is located on the left edge of the picture.

12-Mar-2020: In squamous cell carcinoma, a protein ensures that unneeded proteins are no longer disposed of. A research team at the University of Würzburg has switched off this protein for the first time.

Squamous cell carcinoma is a very unusual type of cancer. They occur in many tissues – for example in the lungs, esophagus, pancreas, throat and pharynx, and on the skin. Due to the many mutations in this type of cancer, treatment is a particularly challenging task for medicine.

However, all squamous cell carcinoma have a common Achilles' heel: They are dependent on the cancer protein ∆NP63. This is a protein that only occurs in this type of tumor and regulates essential biological processes.

An international research team led by Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany, has now found a way to inactivate the cancer protein with the help of another protein and thus curb the growth of squamous cell carcinoma.

Traffic tickets become effective again

The helpful protein is the deubiquitylase USP28, which is particularly common in squamous cell carcinoma. It controls the amount of the cancer protein ∆NP63.

"The deubiquitylase belongs to the so-called ubiquitin-proteasome system, which can be imagined as a towing company," explains Dr. Markus Diefenbacher, group leader at the JMU Chair of Biochemistry and Molecular Biology I. His research group was in charge of the study.

"In healthy cells, this towing company marks ‚incorrectly parked‘ proteins with a kind of parking ticket, namely the protein ubiquitin. "It then towed the parkers away and disposed of them. But the protein can remove the parking ticket and thus prevent the towing. In tumour cells, there is often a loss of traffic wardens/controllers or an accumulation of USP28. Therefore, ∆NP63 in a tumour cell behaves in a similar way to an incorrectly parked car where the parking ticket is permanently removed," explains Diefenbacher.

No direct attack possible

The research team has now been able to prove the dependence of squamous cell carcinoma on the protein USP28: Using a preclinical inhibitor, it switched off ∆NP63's parking ticket remover in the tumor cells. The tumors then stopped growing.

"Many cancer proteins are constructed in such a way that it is not possible to develop a direct active substance against them with the methods currently available," explains the Würzburg researcher. Also, no direct therapeutic attack on the cancer protein ΔNP63 is possible. However, by switching off USP28, the cancer protein could be rapidly degraded in human and animal tumor cells and the tumor could be fought. At the same time, there were no side effects in healthy cells. "We have thus discovered a good new way of attacking squamous cell carcinoma," said Diefenbacher.

Searching for other inhibitors

The inhibitor used is not yet suitable for therapeutic use in humans. It still needs further research. This is done in collaboration with the research group of JMU professor Caroline Kisker at the Rudolf Virchow Centre for Experimental Biomedicine. Diefenbacher: "In cancer therapy, inhibitors are already being used that switch off the entire ubiquitin-proteasome system. Our work now shows a possibility of switching off only one component of this system and thus being able to combat the tumour cells even more specifically.“

Next, Diefenbacher's team will look for further inhibitors that can also be used against USP28. "In addition, we will also look for other proteins in squamous cell carcinoma which these tumours depend on, and investigate whether the ubiquitin-proteasome system can be used to target these proteins for therapy," says the JMU researcher.

Original publication:
Cristian Prieto-Garcia, Oliver Hartmann, Michaela Reissland, Fabian Braun, Thomas Fischer, Susanne Walz, Christina Schülein-Völk, Ursula Eilers, Carsten P. Ade, Marco A. Calzado, Amir Orian, Hans M. Maric, Christian Münch, Mathias Rosenfeldt, Martin Eilers und Markus E. Diefenbacher; "Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells"; EMBO Molecular Medicine; 2020

Facts, background information, dossiers

  • squamous cell carcinoma
  • cancer

More about Uni Würzburg

  • News

    New Molecular Probes for Opioid Receptors

    It could be an important step forward in the improvement of pain therapy: Thanks to newly developed molecular probes, the behavior of individual opioid receptors can now be studied in detail. Strong painkillers are very important in the management of patients with cancer and heart attack o ... more

    Virus multiplication in 3D

    Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies. Two studies now provide fascinating insights into their unusual propagation strategy at the atomic level. For viruses to multiply, they usually need the support of the cells they infect. In ... more

    Achilles Heel of Tumour Cells

    In almost all cases of colon cancer, a specific gene is mutated – this offers opportunities to develop broadly effective therapeutic approaches. Research teams in Würzburg have taken this a step further. In 90 percent of all cases of colon cancer, the tumour cells have one thing in common: ... more

  • q&more articles

    High-tech in the beehive

    Healthy honeybee colonies are crucial to maintaining the natural diversity of flowering plants and the global production of plant-derived foodstuffs. As much as 35 % of this production depends on insect-based pollination, in which the honeybee (Apis mellifera) plays a leading role. For fund ... more

  • Authors

    Prof. Dr. Jürgen Tautz

    studied biology, geography and physics at the University of Konstanz before receiving his doctorate from the University on an ecology-related subject. Work in insect, fish and frog bio-acoustics was followed by his foundation of the BEEgroup at the University of Würzburg in 1994, a group th ... more

  • Videos

    High-tech in the beehive

    more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE